Journal article
The development of stereotactic body radiotherapy in the past decade: A global perspective
SS Lo, BJ Slotman, M Lock, Y Nagata, M Guckenberger, S Siva, M Foote, D Tan, BS Teh, NA Mayr, EL Chang, RD Timmerman, A Sahgal
Future Oncology | Published : 2015
DOI: 10.2217/fon.15.220
Abstract
In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.
Grants
Awarded by Japan Society for the Promotion of Science
Funding Acknowledgements
SS Lo has received honorarium and travel support for a previous educational symposium from Varian Medical Systems and has also received research support from Elekta AB. Ben Slotman has received speaker honorarium and travel support from Varian Medical Systems. RD Timmerman has received research funding from Varian Medical Systems. A Sahgal has received honorarium for previous educational seminars for Medtronic Kyphoplasty division, Elekta AB and Varian Medical Systems and has also received research grants from Elekta AB. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.